PPI analysis also suggested that many enzymes, especially NAD(P)H-quinone oxidoreductase, were enriched in Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease pathways. This evidence concerns the gene NQO1 and Parkinson disease.